Hematopoietic Cell Transplantation is Feasible in Patients with Prior COVID-19 Infection

There are limited data on outcomes of patients with prior Coronavirus disease 2019 (COVID-19) who proceeded to autologous or allogeneic hematopoietic cell transplantation (HCT). Whether these patients are more susceptible to poor outcomes and recurrence of COVID-19 is unknown. We report a retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Nishi, Dahi, Parastoo B., Ponce, Doris M., Sauter, Craig S., Shaffer, Brian C., Chung, David J., Politikos, Ioannis, Lin, Richard J., Giralt, Sergio A., Papanicolaou, Genovefa, Ramanathan, Lakshmi V., Perales, Miguel-Angel, Kamboj, Mini, Shah, Gunjan L., Gyurkocza, Boglarka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. 2022
Materias:
Brief Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503970/
https://www.ncbi.nlm.nih.gov/pubmed/34649021
http://dx.doi.org/10.1016/j.jtct.2021.10.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503970/
https://www.ncbi.nlm.nih.gov/pubmed/34649021
http://dx.doi.org/10.1016/j.jtct.2021.10.004

Ejemplares similares